Table of Contents
Table 5-73: Shelby
Table 5-75: Starke
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 46 | 456.2 | 256 | 521.7 | 30 | 296.0 | 134 | 288.9 |
| Esophagus | * | # | 6 | 12.4** | * | # | 6 | 12.9** |
| Stomach | * | # | 6 | 12.2** | * | # | 4 | # |
| Colon excluding Rectum | 5 | 54.4** | 32 | 69.2 | * | # | 7 | 14.9** |
| Rectum and Rectosigmoid Junction | * | # | 10 | 18.3** | * | # | 1 | # |
| Liver | * | # | 3 | # | * | # | 5 | 9.4** |
| Pancreas | * | # | 6 | 12.4** | * | # | 5 | 10.4** |
| Lung and Bronchus | 10 | 91.7** | 48 | 94.1 | 6 | 54.4** | 43 | 89.2 |
| Melanoma of the Skin | * | # | 6 | 11.0** | * | # | 3 | # |
| Prostate | 8 | 70.8** | 55 | 110.3 | * | # | 11 | 29.1** |
| Urinary Bladder | 5 | 53.8** | 18 | 40.9** | * | # | 6 | 16.7** |
| Kidney and Renal Pelvis | * | # | 13 | 26.9** | * | # | 3 | # |
| Brain and Other Nervous System | * | # | 4 | # | * | # | 2 | # |
| Non-Hodgkin Lymphoma | * | # | 10 | 19.6** | * | # | 8 | 17.6** |
| Myeloma | * | # | 2 | # | * | # | 2 | # |
| Leukemia | * | # | 5 | 10.8** | * | # | 5 | 10.7** |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 54 | 454.5 | 219 | 379.7 | 18 | 147.5** | 89 | 150.6 |
| Colon excluding Rectum | 5 | 39.8** | 23 | 38.4 | * | # | 11 | 18.3** |
| Rectum and Rectosigmoid Junction | * | # | 1 | # | * | # | 0 | # |
| Liver | * | # | 0 | # | * | # | 0 | # |
| Pancreas | * | # | 9 | 15.0** | * | # | 8 | 13.4** |
| Lung and Bronchus | 10 | 86.2** | 32 | 54.7 | * | # | 18 | 30.6** |
| Melanoma of the Skin | * | # | 3 | # | * | # | 0 | # |
| Breast | 15 | 129.5** | 67 | 117.0 | * | # | 10 | 17.1** |
| Cervix Uteri | * | # | 4 | # | * | # | 2 | # |
| Corpus Uteri | * | # | 10 | 17.4** | * | # | 0 | # |
| Ovary | * | # | 8 | 13.8** | * | # | 3 | # |
| Urinary Bladder | * | # | 5 | 8.5** | * | # | 0 | # |
| Kidney and Renal Pelvis | * | # | 3 | # | * | # | 0 | # |
| Brain and Other Nervous System | * | # | 1 | # | * | # | 1 | # |
| Non-Hodgkin Lymphoma | * | # | 11 | 19.6** | * | # | 8 | 14.2** |
| Myeloma | * | # | 2 | # | * | # | 1 | # |
| Leukemia | * | # | 6 | 9.8** | * | # | 5 | 8.2** |
Rates are per 100,000; Age-adjusted, 2000 US Std Population (Census P25-1130).
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, July 2006
Table of Contents
Table 5-73: Shelby
Table 5-75: Starke
